真实世界中大分割放疗的应用:ESTRO-GIRO国际调查
该研究通过2018年1月至2019年1月向放射肿瘤科医生发放匿名电子调查,评估大分割放疗在乳腺癌、前列腺癌、宫颈癌和骨转移中的真实应用情况。结果显示大分割放疗在淋巴结阴性乳腺癌和低/中危前列腺癌中应用较多,姑息适应症中多数受访者偏好大分割,但 curative 适应症和不同地区间存在显著差异。缺乏长期数据和对局部控制及毒性的担忧是最常见障碍。
核心结论
- 大分割放疗在 curative 适应症和不同地区间存在显著差异,姑息治疗中一致性较高。
- 使用不充分的分割方案可能阻碍可负担和可及放疗的提供。
- 需要针对区域和疾病特异性的循证分割方案教育,以及解决实践障碍和支持政策改革的最佳案例。
研究设计与样本
- 匿名电子调查于2018年1月至2019年1月通过ESTRO-GIRO initiative发放给放射肿瘤科医生。
- 共2316名放射肿瘤科医生回复。
- 采用单变量和多变量回归分析识别大分割放疗的预测因素。
主要发现
- 姑息适应症中多数受访者偏好大分割。
- 缺乏长期数据和对局部控制及毒性的担忧是最常提到的障碍。
临床怎么用
- 在姑息适应症中可优先考虑大分割放疗,因多数受访者偏好且一致性较高。
- 对淋巴结阴性乳腺癌保乳术后和低/中危前列腺癌,可参考较高的大分割偏好率进行实践。
- 需关注缺乏长期数据和对局部控制及毒性的担忧,并加强区域和疾病特异性教育。
局限性
- 调查为匿名电子问卷,可能存在应答偏倚。
- 未报告调查回收率或样本代表性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Multiple large trials have established the non-inferiority of hypofractionated radiotherapy compared to conventional fractionation. This study will determine real-world hypofractionation adoption across different geographic regions for breast, prostate, cervical cancer, and bone metastases, and identify barriers and facilitators to its use. MATERIALS AND METHODS: An anonymous, electronic survey was distributed from January 2018 through January 2019 to radiation oncologists through the ESTRO-GIRO initiative. Predictors of hypofractionation were identified in univariable and multivariable regression analyses. RESULTS: 2316 radiation oncologists responded. Hypofractionation was preferred in node-negative breast cancer following lumpectomy (82·2% vs. 46·7% for node-positive; p < 0.001), and in low- and intermediate-risk prostate cancer (57·5% and 54·5%, respectively, versus 41·2% for high-risk (p < 0.001)). Hypofractionation was used in 32·3% of cervix cases in Africa, but <10% in other regions (p < 0.001). For palliative indications, hypofractionation was preferred by the majority of respondents. Lack of long-term data and concerns about local control and toxicity were the most commonly cited barriers. In adjusted analyses, hypofractionation was least common for curative indications amongst low- and lower-middle-income countries, Asia-Pacific, female respondents, small catchment areas, and in centres without access to intensity modulated radiotherapy. CONCLUSION: Significant variation was observed in hypofractionation across curative indications and between regions, with greater concordance in palliation. Using inadequate fractionation schedules may impede the delivery of affordable and accessible radiotherapy. Greater regionally-targeted and disease-specific education on evidence-based fractionation schedules is needed to improve utilization, along with best-case examples addressing practice barriers and supporting policy reform.
引用
- Rodin D, Tawk B, Mohamad O, et al. Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey. Radiother Oncol. 2021. PMID: 33453312. doi:10.1016/j.radonc.2021.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。